Ionis Pharmaceuticals | IONS - Current Liabilities


Ionis Pharmaceuticals reported $717M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Agios Pharmaceuticals USD 58.84M 23.36M Mar/2026
Alnylam Pharmaceuticals USD 1.35B 116.87M Mar/2026
Arrowhead Research USD 295.22M 52.2M Mar/2026
Astellas Pharma JPY 1.22T 106.19B Mar/2026
BioCryst Pharmaceuticals USD 195.39M 675K Mar/2026
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Celltrion KRW 292.71B 9.09B Mar/2026
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
Deva Holding AS TRY 6.43B 1.18B Sep/2023
Divis Laboratories Ltd INR 20.43B 3.15B Mar/2026
Esperion Therapeutics USD 300.36M 451K Mar/2026
Exelixis USD 370.98M 34.67M Mar/2026
Halozyme Therapeutics USD 363.21M 186.12M Mar/2026
Ionis Pharmaceuticals USD 717M 66M Mar/2026
Kangmei Pharma CNY 5.38B 433.79M Mar/2026
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Laboratorios Farma EUR 199.84M 121.75M Dec/2023
Malin Corporation EUR 1000K 500K Dec/2024
Medical Developments International AUD 5.56M 2.26M Dec/2025
Moderna USD 2.4B 408M Mar/2026
Nektar Therapeutics USD 53.54M 12.8M Dec/2025
Neuren Pharmaceuticals AUD 4.34M 3.58M Dec/2025
Neurocrine Biosciences USD 831.7M 88.3M Mar/2026
Novartis USD 31.37B 4.1B Mar/2026
Omeros USD 85.5M 2.28M Jun/2025
OPKO Health USD 148.38M 1.71M Mar/2026
Organigram Holdings CAD 88.74M 5.31M Mar/2026
Ovoca Bio EUR 186K 2.26M Jun/2025
Pfizer USD 34.35B 2.64B Mar/2026
Pharma Mar EUR 89.23M 4.65M Mar/2026
PTC Therapeutics USD 923.6M 44.82M Mar/2026
Qiagen NV USD 512.14M 461.26M Dec/2025
Regeneron Pharmaceuticals USD 5.11B 739.3M Mar/2026
Roche Holding CHF 28B 421M Dec/2025
Sarepta Therapeutics USD 499.16M 596.13M Mar/2026
Sartorius EUR 2.11B 145.8M Mar/2026
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
Tilray USD 259.32M 8.32M Sep/2025
Ultragenyx Pharmaceutical USD 325M 59M Mar/2026
Vertex Pharmaceuticals USD 3.88B 19.4M Mar/2026
Zealand Pharma A/S 664.96M 513.61M Dec/2025
Zz Pientze Pharmaceu CNY 2.28B 134.52M Mar/2026